Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Still Ugly As Ever

By Josh Enomoto, InvestorPlace Contributor

VRX stock has enjoyed a remarkable few days in the markets, but is this a genuine reversal for Valeant Pharmaceutical?

Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Recover

By Josh Enomoto, InvestorPlace Contributor

TEVA stock has been slammed with poor news and fierce competition, but with a little luck, Teva Pharmaceuticals could be a big play in 2017.

Can Staples, Inc. (SPLS) Stock Stand Up Without Office Depot Merger?

By Josh Enomoto, InvestorPlace Contributor

Wall Street is anxiously anticipating the Staples earnings report to see if SPLS stock can stay afloat, but it has taken on too much water.

I Hope You Got Out of Sears Holding Corp (SHLD) Stock, Because It’ll Get Worse

By Josh Enomoto, InvestorPlace Contributor

SHLD stock was a dream come true for the hardcore speculator, but don't let that detract from the truly ugly story of Sears.

The 5 Best Stocks to Buy for Mother’s Day

By Josh Enomoto, InvestorPlace Contributor

Rather than go with the usual, be original this Mother's Day with these five best stocks for Moms everywhere.

Load More